Pure Global

“NanoString” nCounter Dx Analysis System - Taiwan Registration f7ed143ec83afe636cc83bb8a8c6f580

Access comprehensive regulatory information for “NanoString” nCounter Dx Analysis System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f7ed143ec83afe636cc83bb8a8c6f580 and manufactured by NanoString Technologies, Inc. The authorized representative in Taiwan is COLD SPRING BIOTECH CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
f7ed143ec83afe636cc83bb8a8c6f580
Registration Details
Taiwan FDA Registration: f7ed143ec83afe636cc83bb8a8c6f580
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“NanoString” nCounter Dx Analysis System
TW: “納斯凌”微量多基因分析儀
Risk Class 2
MD

Registration Details

f7ed143ec83afe636cc83bb8a8c6f580

Ministry of Health Medical Device Import No. 031951

DHA05603195103

Company Information

United States

Product Details

This product is a clinical multi-standard detection system instrument, which is composed of a preparation workstation and a digital analyzer. The preparation workstation is a liquid handler that automates post-hybridization processing. A digital analyzer is a fluorescence microscope that measures and classifies multiple signals (generated by reporter probes bound to mRNA) from clinical FFPE specimens.

A Clinical chemistry and clinical toxicology

A2570 Clinical Multi-standard Detection System Instrument

Imported from abroad

Dates and Status

Dec 05, 2018

Dec 05, 2028